N (%) | Pretreatment PET SUVmax | |||
---|---|---|---|---|
SUVmax < 5 | SUVmax ≥ 5 | p | ||
All patients | 95 | 40 | 55 | ns |
Histology | ||||
Squamous | 38 (40%) | 8 (20%) | 30 (54.5%) | .046 |
Adenocarcinoma | 33 (34.7%) | 21 (52.5%) | 12 (21.8%) | |
NSCLC NOS | 24 (25.3%) | 11 (27.5%) | 13 (23.7%) | |
Tumor Size [median (range)] | 2.15 (0.8-5.0) cm | 1.95 (0.9-5.0) cm | 2.4 (0.8-4.8) cm | .022 |
T Stage | ||||
1a | 46 (48.4%) | 27 (67.5%) | 19 (34.5%) | .013 |
1b | 30 (31.6%) | 7 (17.5%) | 23 (41.8%) | |
2a | 19 (20%) | 6 (15%) | 13 (23.7%) |